PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SLNO vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


SLNOSPY
YTD Return42.39%26.77%
1Y Return159.56%37.43%
3Y Return (Ann)71.31%10.15%
5Y Return (Ann)19.84%15.86%
10Y Return (Ann)-15.32%13.33%
Sharpe Ratio2.673.06
Sortino Ratio3.194.08
Omega Ratio1.381.58
Calmar Ratio1.664.44
Martin Ratio12.9720.11
Ulcer Index12.38%1.85%
Daily Std Dev60.18%12.18%
Max Drawdown-99.86%-55.19%
Current Drawdown-91.27%-0.31%

Correlation

-0.50.00.51.00.2

The correlation between SLNO and SPY is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

SLNO vs. SPY - Performance Comparison

In the year-to-date period, SLNO achieves a 42.39% return, which is significantly higher than SPY's 26.77% return. Over the past 10 years, SLNO has underperformed SPY with an annualized return of -15.32%, while SPY has yielded a comparatively higher 13.33% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
26.71%
13.38%
SLNO
SPY

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SLNO vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SLNO
Sharpe ratio
The chart of Sharpe ratio for SLNO, currently valued at 2.67, compared to the broader market-4.00-2.000.002.004.002.67
Sortino ratio
The chart of Sortino ratio for SLNO, currently valued at 3.19, compared to the broader market-4.00-2.000.002.004.006.003.19
Omega ratio
The chart of Omega ratio for SLNO, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for SLNO, currently valued at 1.66, compared to the broader market0.002.004.006.001.66
Martin ratio
The chart of Martin ratio for SLNO, currently valued at 12.97, compared to the broader market0.0010.0020.0030.0012.97
SPY
Sharpe ratio
The chart of Sharpe ratio for SPY, currently valued at 3.06, compared to the broader market-4.00-2.000.002.004.003.06
Sortino ratio
The chart of Sortino ratio for SPY, currently valued at 4.08, compared to the broader market-4.00-2.000.002.004.006.004.08
Omega ratio
The chart of Omega ratio for SPY, currently valued at 1.58, compared to the broader market0.501.001.502.001.58
Calmar ratio
The chart of Calmar ratio for SPY, currently valued at 4.44, compared to the broader market0.002.004.006.004.44
Martin ratio
The chart of Martin ratio for SPY, currently valued at 20.11, compared to the broader market0.0010.0020.0030.0020.11

SLNO vs. SPY - Sharpe Ratio Comparison

The current SLNO Sharpe Ratio is 2.67, which is comparable to the SPY Sharpe Ratio of 3.06. The chart below compares the historical Sharpe Ratios of SLNO and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
2.67
3.06
SLNO
SPY

Dividends

SLNO vs. SPY - Dividend Comparison

SLNO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.17%.


TTM20232022202120202019201820172016201520142013
SLNO
Soleno Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.17%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%1.81%

Drawdowns

SLNO vs. SPY - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SLNO and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-91.27%
-0.31%
SLNO
SPY

Volatility

SLNO vs. SPY - Volatility Comparison

Soleno Therapeutics, Inc. (SLNO) has a higher volatility of 7.49% compared to SPDR S&P 500 ETF (SPY) at 3.88%. This indicates that SLNO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
7.49%
3.88%
SLNO
SPY